V Lavoipierre, M Talbot, C Soubrier, B De Sainte Marie, V Seux, C Solas, P Morange, E Bernit, M Ebbo, B Faucher, J R Harlé, N Schleinitz
La Revue de medecine interne 2020 JulAdrenal hemorrhage is a classical but rare complication of antiphospholipid syndrome, revealing diagnosis in one third of the cases. Anti-vitamin K therapy is the standard treatment but direct oral anticoagulants are discussed as an alternative. In the latest recommendations, it is advised not to use direct oral anticoagulants in the setting of antiphospholipid syndrome. We present a case of bilateral adrenal hemorrhage revealing primary antiphospholipid syndrome with triple positive antibody profile, in a 47-year-old man treated by apixaban for previous venous thromboembolism. To our knowledge, it is the first case of adrenal hemorrhage occurring during apixaban treatment in a patient with antiphospholipid syndrome. This case illustrates the inefficacy of direct oral anticoagulants to prevent thrombotic events in antiphospholipid syndrome, in accordance with the latest recommendations. Copyright © 2019 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
V Lavoipierre, M Talbot, C Soubrier, B De Sainte Marie, V Seux, C Solas, P Morange, E Bernit, M Ebbo, B Faucher, J R Harlé, N Schleinitz. Bilateral adrenal hemorrhage under apixaban in primary antiphospholipid syndrome]. La Revue de medecine interne. 2020 Jul;41(7):489-492
PMID: 31672255
View Full Text